Several new semi-synthetic coumermycin analogs, which carry a polar substituent at the C-3 amide moiety have been prepared. In vitro antibacterial activity of these new analogs against Gram-positive organisms, particularly methicillin-resistant strains of Staphylococci species has been described.
No takes yet. Share an insight, caveat, or question.
Ueda et al. (1989) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: